Ben Ayers is an experienced healthcare professional currently serving as the Vice President of Antibody-Drug Conjugates at Hummingbird Bioscience. Their career spans various roles, including Postdoctoral Research Associate at Nanyang Technological University and Investigator at Novartis. Ben's extensive background also includes positions at the University of Oxford and The Institute of Cancer Research, culminating in a D.Phil in Organic Chemistry from Oxford. Additionally, Ben held strategic roles at ZS and Hummingbird Bioscience, showcasing a strong expertise in both discovery and commercial strategy.
This person is not in any teams
This person is not in any offices